Search results
Nov 1, 2022 · NEW BRUNSWICK, N.J. & DANVERS, Mass.-- ( BUSINESS WIRE )--Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world ...
Mar 29, 2024 · Since Abiomed’s first notice about the Impella’s complications in October 2021, the F.D.A. received 21 additional reports of heart-wall tears linked to patient deaths, according to Audra ...
Johnson & Johnson Completes Acquisition of Abiomed. December 22, 2022. Learn More. Recovering Hearts. Saving Lives. Abiomed is a leading provider of groundbreaking medical technology that provides circulatory support.
Sep 30, 2022 · ABOUT ABIOMED. Based in Danvers, Massachusetts, USA, Abiomed, Inc., is a leading provider of medical technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information, please visit: www.abiomed.com ...
Apr 7, 2024 · A late breaking clinical trial, presented at the American College of Cardiology conference and simultaneously published in the New England Journal of Medicine, confirms routine use of Impella CP in patients who have had a heart attack with STEMI cardiogenic shock reduces 180-day mortality by 12.7%, compared to the control arm (45.8% vs. 58.5%, p=0.04).
Dec 5, 2022 · December 5, 2022 5 min read. DANVERS, Mass., Dec. 5, 2022 – Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and ...
Abiomed Breethe OXY-1 System Device Indication & Safety Information. The OXY-1 System is intended to be used for extracorporeal circulation. The OXY-1 System pumps, oxygenates and removes carbon dioxide from blood ... The OXY-1 System must be operated and/or monitored by users with specialized training in extracorporeal circulation therapy.
